In addition, although overweight and obesity is markedly more common, some individuals with advanced HF like HFrEF are also cachexic (Rossignol et al., 2015) and may therefore not benefit from the weight-reducing effect of GLP-1 RAs. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.